Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment
<p>Abstract</p> <p>Background</p> <p>Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma. The expression of OPN in allergic rhinitis...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Online Access: | http://www.aacijournal.com/content/6/1/28 |
id |
doaj-35205e7ab1fa4616844a5e00d7557dfb |
---|---|
record_format |
Article |
spelling |
doaj-35205e7ab1fa4616844a5e00d7557dfb2020-11-24T20:47:26ZengBMCAllergy, Asthma & Clinical Immunology1710-14841710-14922010-11-01612810.1186/1710-1492-6-28Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatmentO'Neil Serena EMalmhäll CarinaSamitas KonstantinosPullerits TeetBossios ApostolosLötvall Jan<p>Abstract</p> <p>Background</p> <p>Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma. The expression of OPN in allergic rhinitis (AR) is currently unknown, as is the effect of intranasal glucocorticosteroids (GCs) on that expression.</p> <p>Methods</p> <p>Subjects with AR were randomised to receive treatment with fluticasone propionate (FP) (n = 12) or a placebo (n = 16) over the grass pollen season and nasal biopsies were taken prior to, and during the season. OPN expression in the nasal mucosa was examined with immunohistochemistry. Healthy non-AR controls (n = 5) were used as a comparator.</p> <p>Results</p> <p>OPN expression was detected in epithelial cells, subepithelial infiltrating/inflammatory cells and cells lining the vessels and glands of all subjects. Comparison of the pre- and peak-pollen season biopsy sections in placebo treated patients revealed no increase in OPN expression during the grass pollen season (5.7% vs 6.4%). Treatment with a local glucocorticosteroid did not alter the expression of OPN during pollen exposure (6.2% vs 6.7%).</p> <p>Conclusion</p> <p>OPN has been increasingly associated with the pathogenesis of various Th2-mediated diseases. However, our finding that the OPN expression in the nasal mucosa of AR patients is not significantly affected by allergen exposure and is comparable to that of the healthy controls, suggests that intracellular OPN is not directly involved in the pathogenesis of allergic rhinitis.</p> http://www.aacijournal.com/content/6/1/28 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
O'Neil Serena E Malmhäll Carina Samitas Konstantinos Pullerits Teet Bossios Apostolos Lötvall Jan |
spellingShingle |
O'Neil Serena E Malmhäll Carina Samitas Konstantinos Pullerits Teet Bossios Apostolos Lötvall Jan Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment Allergy, Asthma & Clinical Immunology |
author_facet |
O'Neil Serena E Malmhäll Carina Samitas Konstantinos Pullerits Teet Bossios Apostolos Lötvall Jan |
author_sort |
O'Neil Serena E |
title |
Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment |
title_short |
Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment |
title_full |
Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment |
title_fullStr |
Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment |
title_full_unstemmed |
Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment |
title_sort |
quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment |
publisher |
BMC |
series |
Allergy, Asthma & Clinical Immunology |
issn |
1710-1484 1710-1492 |
publishDate |
2010-11-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma. The expression of OPN in allergic rhinitis (AR) is currently unknown, as is the effect of intranasal glucocorticosteroids (GCs) on that expression.</p> <p>Methods</p> <p>Subjects with AR were randomised to receive treatment with fluticasone propionate (FP) (n = 12) or a placebo (n = 16) over the grass pollen season and nasal biopsies were taken prior to, and during the season. OPN expression in the nasal mucosa was examined with immunohistochemistry. Healthy non-AR controls (n = 5) were used as a comparator.</p> <p>Results</p> <p>OPN expression was detected in epithelial cells, subepithelial infiltrating/inflammatory cells and cells lining the vessels and glands of all subjects. Comparison of the pre- and peak-pollen season biopsy sections in placebo treated patients revealed no increase in OPN expression during the grass pollen season (5.7% vs 6.4%). Treatment with a local glucocorticosteroid did not alter the expression of OPN during pollen exposure (6.2% vs 6.7%).</p> <p>Conclusion</p> <p>OPN has been increasingly associated with the pathogenesis of various Th2-mediated diseases. However, our finding that the OPN expression in the nasal mucosa of AR patients is not significantly affected by allergen exposure and is comparable to that of the healthy controls, suggests that intracellular OPN is not directly involved in the pathogenesis of allergic rhinitis.</p> |
url |
http://www.aacijournal.com/content/6/1/28 |
work_keys_str_mv |
AT oneilserenae quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment AT malmhallcarina quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment AT samitaskonstantinos quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment AT pulleritsteet quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment AT bossiosapostolos quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment AT lotvalljan quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment |
_version_ |
1716810063800172544 |